Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation

Cell Transplantation

Volumn 14, Issue 7, 2005, Pages 457-467

  Silva Barbosa, Suse Dayse ^a,b,c   Butler Browne, Gillian S ^a   Di Santo, James P ^b   Mouly, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Immunodeficient mice; MyHC; Skeletal muscle; Transplantation

Indexed keywords

CARDIOTOXIN; COMPLEMENT COMPONENT C5; RAG2 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL REGENERATION; CELL TRANSPLANTATION; COMPARATIVE STUDY; CYTOFLUOROMETRY; EVALUATION; GENETIC ENGINEERING; HOST CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; INFLAMMATORY CELL; MOUSE; MOUSE STRAIN; MUSCLE DISEASE; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; TIBIALIS ANTERIOR MUSCLE; XENOGRAFT;

ANIMALIA;

EID: 27644526963     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783982837     Document Type: Article

References (32)

1. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1113-1122; 1999.
2. Cao, X.; Shores, E. W.; Hu-Li, J.; et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-238; 1995.
3. Colucci, F.; Soudais, C.; Rosmaraki, E.; Vanes, L.; Tybulewicz, V. L.; Di Santo, J. P. Dissecting NK cell development using a novel alymphoid mouse model: Investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162:2761-2765; 1999.
4. Cooper, R. N.; Irintchev, A.; Di Santo, J. P.; Zweyer, M.; Morgan, J. E.; Partridge, T. A.; Butler-Browne, G. S.; Mouly, V.; Wernig, A. A new immunodeficient mouse model for human myoblast transplantation. Hum. Gene Ther. 12:823-831; 2001.
5. Cooper, R. N.; Thiesson, D.; Furling, D.; Di Santo, J. P.; Butler-Browne, G. S.; Mouly, V. Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation. Hum. Gene Ther. 14:1169-1179; 2003.
6. Decary, S.; Mouly, V.; Butler-Browne, G. S. Telomere length as a tool to monitor satellite cell amplification for cell-mediated gene therapy. Hum. Gene Ther. 7:1347-1350; 1996.
7. Edom, F.; Mouly, V.; Barbet, J. P.; Fiszman, M. Y.; Butler-Browne, G. S. Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains. Dev. Biol. 164:219-229; 1994.
8. Fan, Y.; Maley, M.; Beilharz, M.; Grounds, M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-860; 1996.
9. Gabe, S. M.; Bjarnason, I.; Tolou-Ghamari, Z.; et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 115:67-74; 1998.
10. Gussoni, E.; Pavlath, G. K.; Lanctot, A. M.; et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356:435-438; 1992.
11. Hodgetts, S. I.; Spencer, M. J.; Grounds, M. D. A role for natural killer cells in the rapid death of cultured donor myoblast after transplantation. Transplantation 75(6):863-871; 2003.
12. Hojo, M.; Hoshimaru, M.; Miyamoto, S.; Taki, W.; Kikuchi, H.; Hashimoto, N. A cerebrospinal fluid protein associated with moyamoya disease: Report of three cases. Neurosurgery 45:170-173; 1999.
13. Huard, J.; Verreault, S.; Roy, R.; Tremblay, M.; Tremblay, J. P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93:586-599; 1994.
14. Irintchev, A.; Langer, M.; Zweyer, M.; Theisen, R.; Wernig, A. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J. Physiol. 500(Pt. 3):775-785; 1997.
15. Louboutin, J. P.; Fichter-Gagnepain, V.; Thaon, E.; Fardeau, M. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul. Disord. 3:463-469; 1993.
16. Mazurier, F.; Fontanellas, A.; Salesse, S.; et al. A novel immunodeficient mouse model-RAG2 × common cytokine receptor gamma chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 19:533-541; 1999.
17. Mendell, J. R.; Kissel, J. T.; Amato, A. A.; et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:832-838; 1985.
18. Merly, F.; Lescaudron, L.; Rouaud, T.; Crossin, F.; Gardahaut, M. F. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22:724-732; 1999.
19. Moretta, A.; Bottino, C.; Vitale, M.; et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223; 2001.
20. Morgan, J. E.; Gross, J. G.; Pagel, C. N.; et al. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J. Cell Biol. 157:693-702; 2002.
21. Murphy, W. J.; Durum, S. K.; Anver, M. R.; et al. Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J. Immunol. 153:1004-1014; 1994.
22. Partridge, T. A.; Morgan, J. E.; Coulton, G. R.; Hoffman, E. P.; Kunkel, L. M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176-179; 1989.
23. Pavlath, G. K.; Rando, T. A.; Blau, H. M. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 127:1923-1932; 1994.
24. Rosenblatt, J. D.; Parry, D. J.; Partridge, T. A. Phenotype of adult mouse muscle myoblasts reflects their fiber type of origin. Differentiation 60:39-45; 1996.
25. Schultz, E.; Jaryszak, D. L.; Valliere, C. R. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8:217-222; 1985.
26. Shinkai, Y.; Rathbun, G.; Lam, K. P.; et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867; 1992.
27. Skuk, D.; Roy, B.; Goulet, M.; Chapdelaine, P.; Bouchard, J. P.; Roy, R.; Dugre, F. J.; Lachance, J. G.; Deschenes, L.; Helene, S.; Sylvain, M.; Tremblay, J. P. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 9:475-482; 2004.
28. Skuk, D.; Tremblay, J. P. Cell therapies for inherited myopathies. Curr. Opin. Rheumatol. 15:723-729; 2003.
29. Skuk, D.; Tremblay, J. P. Complement deposition and cell death after myoblast transplantation. Cell Transplant. 7:427-434; 1998.
30. Smythe, G. M.; Hodgetts, S. I.; Grounds, M. D. Problems and solutions in myoblast transfer therapy. J. Cell. Mol. Med. 5:33-47; 2001.
31. Spencer, M. J.; Montecino-Rodriguez, E.; Dorshkind, K.; Tidball, J. G. Helper CD4(+) and cytotoxic CD8(+) T cells promote the pathology of dystrophin-deficient muscle. Clin. Immunol. 98:235-243; 2001.
32. Watt, D. J.; Morgan, J. E.; Clifford, M. A.; Partridge, T. A. The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat. Embryol. (Berl.) 175:527-536; 1987.